A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Hematologic Malignancies
Related studies linked through entity extraction aliases.
Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab
- Status
- RECRUITING
- Phase
- PHASE2
Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L.
- Status
- COMPLETED
- Phase
- NA
ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
- Status
- RECRUITING
- Phase
- NA
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
IVIG for Infection Prevention After CAR-T-Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
- Status
- RECRUITING
- Phase
- PHASE1
The Effect of Lavender Oil on Fatigue and Sleep Quality
- Status
- UNKNOWN
- Phase
- NA
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
- Status
- RECRUITING
- Phase
- N/A
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology
- Status
- UNKNOWN
- Phase
- NA
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2